Avient Corporation (AVNT) Income Statement

The latest quarter's 10.5% growth is a meaningful acceleration against a fairly flat trailing trend, which suggests the recovery may be concentrated in recent periods rather than a sustained expansion. Investors should check whether the Q3 2026 uplift reflects volume recovery in packaging and healthcare or pricing pass-through of resin costs, since the two imply very different durability. Without a clear breakdown, the growth profile should be treated as tentative rather than structurally improving.

The stability of gross margin across resin price cycles suggests pricing power in the specialty portfolio, although the dip to 30.4% and 30.5% in recent quarters may reflect the price-to-raw lag during input cost movements. The gap between peak and trough margins is narrow enough that the business appears less cyclical than its plastics exposure would imply. Continued monitoring of mix shift toward healthcare and composites will indicate whether margins can recover toward the mid-30s.

Operating income is scaling more slowly than gross profit in the most recent periods, which suggests overhead is not yet being leveraged across the expanded revenue base. The persistent SG&A load, roughly 21% of revenue in recent quarters, may partly reflect integration costs from recent acquisitions, though the data does not isolate those items. Whether SG&A efficiency improves as integration matures will be a key test of the operating model.